ConductScience.org, home

Paper7199538

Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.

Sakata Y and 1 other. J Clin Invest, 1982. Cited by 268 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis. Papers, record 7199538. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7199538

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Significance of cross-linking of alpha 2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis.
PubMed
Journal
J Clin Invest
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
268
iCite
Relative citation ratio, by iCite
8.41
iCite
Revised in PubMed
2019-06-06
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakata YY
2Aoki NN

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrinMajor topic
FibrinolysisMajor topic
HemostasisMajor topic
alpha-2-AntiplasminMajor topic
Calcium
Factor XIII
Humans
Plasminogen
Plasminogen Activators

Source PubMed

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14,974,323[A quantitative determination of factor 13 with anti-factor 13 serum].Thromb Diath Haemorrh1968https://conductscience.org/library/papers/4974323PubMed
25,806,584The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.J Biol Chem1969https://conductscience.org/library/papers/5806584PubMed
35,105,032A rapid method for the purification of bovine thrombin and the inhibition of the purified enzyme wtih phenylmethylsulfonyl fluoride.Biochemistry1971https://conductscience.org/library/papers/5105032PubMed
44,257,942Characterization of human plasminogen. II. Separation and partial characterization of different molecular forms of human plasminogen.Biochim Biophys Acta1972https://conductscience.org/library/papers/4257942PubMed
54,623,561Kinetic studies with transglutaminases. The human blood enzymes (activated coagulation factor 13 and the guinea pig hair follicle enzyme.J Biol Chem1972https://conductscience.org/library/papers/4623561PubMed
65,065,068Solid state lactoperoxidase: a highly stable enzyme for simple, gentle iodination of proteins.Biochem Biophys Res Commun1972https://conductscience.org/library/papers/5065068PubMed
74,405,643Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.J Biol Chem1973https://conductscience.org/library/papers/4405643PubMed
81,158,872Cross-linking of cold-insoluble globulin by fibrin-stabilizing factor.J Biol Chem1975https://conductscience.org/library/papers/1158872PubMed
9134,998Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.J Biol Chem1976https://conductscience.org/library/papers/134998PubMed
10136,345Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.Eur J Biochem1976https://conductscience.org/library/papers/136345PubMed
11137,718The primary inhibitor of plasmin in human plasma.Biochem J1976https://conductscience.org/library/papers/137718PubMed
121,011,990Fibrin-stabilizing factor (factor XIII).Methods Enzymol1976https://conductscience.org/library/papers/1011990PubMed
1368,962The behavior of alpha2-plasmin inhibitor in fibrinolytic states.J Clin Invest1977https://conductscience.org/library/papers/68962PubMed
14144,728Inhibition of proteases in coagulation, kinin-forming and complement systems by alpha2-plasmin inhibitor.J Biochem1977https://conductscience.org/library/papers/144728PubMed
15147,116Fast-acting plasmin inhibitor in human plasma.Blood1978https://conductscience.org/library/papers/147116PubMed
1676,519The alpha2-plasmin inhibitor levels in liver diseases.Clin Chim Acta1978https://conductscience.org/library/papers/76519PubMed
1777,050Effects of alpha2-plasmin inhibitor on fibrin clot lysis. Its comparison with alpha2-macroglobulin.Thromb Haemost1978https://conductscience.org/library/papers/77050PubMed
18659,588Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis.J Clin Invest1978https://conductscience.org/library/papers/659588PubMed
19151,345Assay of alpha2-plasmin inhibitor activity by means of a plasmin specific tripeptide substrate.Thromb Res1978https://conductscience.org/library/papers/151345PubMed
20154,122Natural inhibitors of fibrinolysis.Prog Cardiovasc Dis1979https://conductscience.org/library/papers/154122PubMed

See all 26 references

Cited by51

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 268 citations.

PMIDTitleJournalYearIn PapersSource
42,982,814Transglutaminase 2 contributes to the blood clotting cascade.Cell Death Discov2026https://conductscience.org/library/papers/42982814PubMed
41,303,589Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side Effects.Int J Mol Sci2025https://conductscience.org/library/papers/41303589PubMed
39,519,297Localization of Hemostasis Elements in Aspirated Coronary Thrombi at Different Stages of Evolution.Int J Mol Sci2024https://conductscience.org/library/papers/39519297PubMed
38,706,781Connecting impaired fibrinolysis and dyslipidemia.Res Pract Thromb Haemost2024https://conductscience.org/library/papers/38706781PubMed
37,332,750All tangled up: interactions of the fibrinolytic and innate immune systems.Front Med (Lausanne)2023https://conductscience.org/library/papers/37332750PubMed
37,153,474"Super" SERPINs-A stabilizing force against fibrinolysis in thromboinflammatory conditions.Front Cardiovasc Med2023https://conductscience.org/library/papers/37153474PubMed
36,531,720"Going with the flow" in modeling fibrinolysis.Front Cardiovasc Med2022https://conductscience.org/library/papers/36531720PubMed
36,452,200Plasmin Inhibitor in Health and Diabetes: Role of the Protein as a Therapeutic Target.TH Open2022https://conductscience.org/library/papers/36452200PubMed
35,328,366The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis.Int J Mol Sci2022https://conductscience.org/library/papers/35328366PubMed
35,163,216Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm.Int J Mol Sci2022https://conductscience.org/library/papers/35163216PubMed
34,967,721Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism.Blood Transfus2022https://conductscience.org/library/papers/34967721PubMed
34,830,419Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.Int J Mol Sci2021https://conductscience.org/library/papers/34830419PubMed
33,540,604Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis.Int J Mol Sci2021https://conductscience.org/library/papers/33540604PubMed
33,426,005Alpha2-Antiplasmin: The Devil You Don't Know in Cerebrovascular and Cardiovascular Disease.Front Cardiovasc Med2020https://conductscience.org/library/papers/33426005PubMed
31,258,531Fibrinolysis and Inflammation in Venous Thrombus Resolution.Front Immunol2019https://conductscience.org/library/papers/31258531PubMed
29,779,246Regulation of plasminogen activation on cell surfaces and fibrin.J Thromb Haemost2018https://conductscience.org/library/papers/29779246PubMed
29,723,259Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasmin.PLoS One2018https://conductscience.org/library/papers/29723259PubMed
29,378,352Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.Thromb Haemost2018https://conductscience.org/library/papers/29378352PubMed
29,080,382Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.J Thromb Haemost2018https://conductscience.org/library/papers/29080382PubMed
28,761,875Inhibition of Fibrinolysis by Coagulation Factor XIII.Biomed Res Int2017https://conductscience.org/library/papers/28761875PubMed

See all 51 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PLG5,340PubTator's text mininghttps://conductscience.org/library/genes/5340NCBI Gene
SERPINF25,345PubTator's text mininghttps://conductscience.org/library/genes/5345NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7199538

GET https://conductscience.org/api/papers/v1/7199538/references?page=2